unknown
Stage
About
EarliPoint Health develops an FDA-cleared medical device that uses eye-tracking technology to aid clinicians in the early diagnosis and assessment of autism spectrum disorders in young children by providing objective, quantifiable data to support clinical evaluations.
Explore EarliPoint Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.